Skip to main navigation Skip to search Skip to main content

Similar Risk of Renal Events Among Patients Treated With Tenofovir or Entecavir for Chronic Hepatitis B

  • Robert G. Gish
  • , Margaret D. Clark
  • , Steve D. Kane
  • , Richard E. Shaw
  • , Michael F. Mangahas
  • , Sumbella Baqai

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)941-946
Number of pages6
JournalClinical Gastroenterology and Hepatology
Volume10
Issue number8
DOIs
StatePublished - Aug 2012
Externally publishedYes

ASJC Scopus Subject Areas

  • Hepatology
  • Gastroenterology

Keywords

  • Adverse event
  • Hepatitis b virus
  • Kidney damage
  • Side effect
  • Glomerular Filtration Rate
  • Organophosphonates/administration & dosage
  • Risk Assessment
  • Humans
  • Middle Aged
  • Male
  • Creatinine/blood
  • Hepatitis B, Chronic/drug therapy
  • Tenofovir
  • Young Adult
  • Guanine/administration & dosage
  • Adult
  • Female
  • Aged
  • Retrospective Studies
  • Antiviral Agents/administration & dosage
  • Adenine/administration & dosage
  • Kidney Diseases/chemically induced
  • Cohort Studies

Cite this